BCAR1 and non-small cell lung carcinoma: Analysis of gray scales of immunoblotting suggested there was no appreciable difference of BCAR1 levels in between NSCLC and the normal adjacent tissue (25.3±11.2 vs 27.8±15.2, P = 0.476, Student's t-test, Figure 1b).